Clinical Trials Logo

CHF clinical trials

View clinical trials related to CHF.

Filter by:

NCT ID: NCT03905252 Recruiting - CHF Clinical Trials

Biomarkers for Human Heart Failure

Biomarkers
Start date: August 2009
Phase:
Study type: Observational

The purpose of this study is to establish the various ranges of proteins that can be assayed in the plasma and urine from hospitalized patients with all classes of heart failure and/or STEMI (ST-segment elevation myocardial infarction)/NSTEMI (Non-ST-segment elevation myocardial infarction), as well as history reviews.

NCT ID: NCT03899298 Recruiting - Stroke Clinical Trials

Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions

Start date: March 20, 2019
Phase: Phase 1
Study type: Interventional

To determine the safety and efficacy of Amniotic and Umbilical Cord Tissue for the treatment of the following condition categories: Orthopedic, Neurologic, Urologic, Autoimmune, Renal, Cardiac and Pulmonary Conditions. The hypotheses are that the treatments are not only extremely safe, but also statistically beneficial for all conditions. Outcomes will be determined by numerous valid outcome instruments that compile general quality of life information along with condition-specific information as well.

NCT ID: NCT03808948 Enrolling by invitation - CHF Clinical Trials

FAST PV and mGFR™ Technology in Congestive Heart Failure

Start date: January 10, 2019
Phase: N/A
Study type: Interventional

This is an investigator-initiated, one-armed, phase 2 clinical trial using an injectable fluorescent tracer to assay and evaluate measured plasma volume (mPV) and measured glomerular filtration rate (mGFR) in hospitalized patients with acute decompensated congestive heart failure (CHF).

NCT ID: NCT03463148 Enrolling by invitation - Hypertension Clinical Trials

Validation of a Sensor for Non-Invasive Measurements

Start date: October 24, 2017
Phase:
Study type: Observational

Subjects will be measured with both a sensor and a reference device

NCT ID: NCT03339310 Active, not recruiting - Heart Failure Clinical Trials

Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System

FIX-HF-5C2
Start date: October 23, 2017
Phase: N/A
Study type: Interventional

This is a multicenter, prospective, single-arm study of the Optimizer Smart System with 2-leads

NCT ID: NCT03207802 Enrolling by invitation - CHF Clinical Trials

Remotely Monitoring Patients With Chronic Conditions in Their Home

Start date: June 21, 2017
Phase: N/A
Study type: Observational

Study will collect data from the home using the CoVa Monitoring System. Data will be captured and retrospectively analysis to determine if the data provided can alert clinician about a patient's declining health.

NCT ID: NCT03102437 Recruiting - Heart Failure Clinical Trials

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

FIX-HF-5CA
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

This is a multicenter, prospective, single-arm Continued Access study of the Optimizer Smart System with CCM therapy.

NCT ID: NCT03002311 Enrolling by invitation - Depression Clinical Trials

Improving Medical Care With Electronic Interventions Based on Automated Text and Phone Messages

Start date: January 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study's purpose is to test the effects of an electronic health intervention platform developed by Epharmix, which features two-way SMS text messages and phone calls intended to improve clinical outcomes compared to the standard of care. The investigators hypothesize that this system can improve frequency and quality of data gathering across various specialties, leading to expedited provider intervention and improved health outcomes.

NCT ID: NCT02873000 Not yet recruiting - COPD Clinical Trials

Incentive Spirometry in Non-critically Ill Hospitalized Patients With Acute Respiratory Failure

Start date: April 2017
Phase: N/A
Study type: Interventional

To evaluate the use of Incentive Spirometry in Non-critically Ill Hospitalized Patients With Shortness of Breath.

NCT ID: NCT02632552 Recruiting - COPD Clinical Trials

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

TACT
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.